2m 2m 2m 2m 2m 2m 2m
BONE BIO (BBLG)
NASDAQ
$1.41+$0.03 (+1.81%)
Price as of Jun 23, 2026 5:47 PM EDT- $2.5MMarket Cap
- -77.90%1-Year Change
- BiotechnologyIndustry
BONE BIO (BBLG)
$1.41+$0.03 (+1.81%)
BBLG | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.38 | ||
Change | -$0.09 (-6.16%) | ||
Open | $1.33 | ||
High | $1.43 | ||
Low | $1.28 | ||
Previous Close | $1.37 | ||
Volume | 49,052 | ||
30-Day Average Volume | 125,464 | ||
1-Week Change | -4.86% | ||
1-Month Change | 12.30% | ||
1-Year Change | -77.90% | ||
3-Year Change | -98.10% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 1.8M | ||
Total Assets | $5.0M | ||
Market Cap | $2.5M | ||
Enterprise Value | -$2.1M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$800,000.00 | ||
Free Cash Flow | -$804,282.00 | ||
EBIT | -$800,000.00 | ||
EBITDA | -$800,000.00 | ||
Net Working Capital | $4.7M | ||
EPS | -$0.43 | ||
Enterprise Value/EBITDA | 3 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -3 | ||
PEG | N/A | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 6 | ||
Last Split Date | 06/10/2025 | ||
Earnings & Revenue